Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status

Small-cell lung cancer (SCLC) is highly sensitive to platinum-based chemotherapy. However, its indication in patients with a poor performance status (PS) at initial diagnosis is controversial. We retrospectively reviewed all clinical courses of pathologically diagnosed SCLC patients with poor PS, Ea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Oncol
Hlavní autoři: Aida, Yuka, Nakazawa, Kensuke, Shiozawa, Toshihiro, Ogawa, Ryoko, Kiwamoto, Takumi, Morishima, Yuko, Sakamoto, Toru, Sekine, Ikuo, Hizawa, Nobuyuki
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2019
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738152/
https://ncbi.nlm.nih.gov/pubmed/31543777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501548
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky